Position in LLY
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$4,265,173
+$1,365,139 QoQ
Shares Held
3,556
+12.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.68%
of 13F equity value
Holder Rank
#1,837
of 4,605 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026New England Research & Management, Inc. holds $31,997,185 across 8 Drug Manufacturers - General names. LLY ranks #4 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
29,527 | $7,498,972 | |
| 2 | ABBV |
AbbVie Inc.
|
24,774 | $6,234,129 | |
| 3 | AMGN |
Amgen Inc
|
11,880 | $4,301,985 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
3,556 | $4,265,173 | |
| 5 | MRK |
Merck & Co., Inc.
|
27,279 | $3,505,351 | |
| 6 | AZN |
Astrazeneca PLC
|
15,893 | $3,013,630 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
21,070 | $2,661,983 | |
| 8 | PFE |
Pfizer Inc
|
21,427 | $515,962 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,265,173 | 3,556 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $2,900,034 | 3,153 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,553,439 | 2,376 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $1,862,483 | 2,441 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $2,183,463 | 2,801 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $2,239,042 | 2,711 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $1,853,572 | 2,401 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $2,308,759 | 2,606 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $1,770,923 | 1,956 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $1,696,730 | 2,181 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $1,594,286 | 2,735 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $907,749 | 1,690 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $841,819 | 1,795 | Shares | Sole | 2023-07-05 | |
| 2023-03-31 | $959,858 | 2,795 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $546,930 | 1,495 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $483,408 | 1,495 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $416,635 | 1,285 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $410,654 | 1,434 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $361,848 | 1,310 | Shares | Sole | 2022-01-05 | |
| 2021-09-30 | $302,675 | 1,310 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $681,674 | 2,970 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $259,679 | 1,390 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $956,478 | 5,665 | Shares | Sole | 2021-01-07 | |
| 2020-09-30 | $1,759,957 | 11,890 | Shares | Sole | 2020-10-08 | |
| 2020-03-31 | $1,163,860 | 8,390 | Shares | Sole | 2020-06-15 | |
| No filing history on record for this holder in this stock. | ||||||